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Preparation and in vifro activity of controlled release 
microspheres incorporating bFGF 
SHEN Bin &#, PEI Fu-Xing sBg * , DUAN Hong BE, CHEN Jian E g  and MU Jim-xiong *,&@ 
Objective: To study the preparative method of 
controlled release microspheres incorporating basic 
fibroblast growth factor ( bFGF) and the bioactivities of 
bFGF, which were released from bFGF microspheres, on 
the cultured Schwann cells. 
Methods : bFGF was microcapsulated with the 
multiple emulsion encapsdative method using polylactic-co- 
glycolic acid ( PLGA) as coating material. Its morphology, 
particle size distribution, drug loading, enveloping rate and 
in vitro release property were studied. The cultured 
Schwann cells were grouped according to the different 
ingredients being added to the culture medium of bFGF 
group or bFGF-PLGA group. Then the cytometry, 
cytoactivity detection and mitotic cycle analysis of Schwann 
cells were performed. 
Results: The morphology and the particle size 
distribution of the bFGF-PLGA microspheres were even 
and good. The drug loading and enveloping rate of 
microspheres were (27.18 x 10' ) % i (0.51 x loJ ) % and 
66.43% *l. 24%. The release property of microspheres in 
v i a 0  was good and the overall release rate was 72.47% in 
11 days. The in v i a 0  cellular study showed that: at the first 
asic fibroblast growth factor ( bFGF) has been 
proved to have mitogenic and differentiation- 
promoting effect on neuroectodermal cells, and it 
has great applicable potentials in the research field of 
nerve regeneration. ' However, because of the 
instability in the heat and acid environment, along with 
a short half-life time ( TI,* ) of 3-5 minutes in vivo , 
bFGF cannot satisfy the need for clinical applications 
either universally or locally. So it is meaningful to find 
out a controlled release agent of bFGF by which to 
maintain a prolonged effective drug concentration and 
improve nerve regeneration. 3*4 
2 days of plate culture, the cell number and viability of the 
bFGF group were statistically higher than the bFGF-PLGA 
group; at the 3rd and 4th days of plate culture, the cell 
number and viability of bFGF and bFGF-PLGA groups 
showed no diierence; at the 6th and 8th days of the plate 
culture, the cell number and viability of the bFGF-PLGA 
group were statistically higher than the bFGF group. By 
flow cytometry examination, at the 2nd day of plate 
culture, the G2/M + S percentage of bFGF group was 
statistically higher than the bFGF-PLGA group, at the 4th 
and 8th days of plate culture, the G2/M + S percentage of 
the bFGF-PLGA group was statistically higher than the 
bFGF group. 
It is practical to prepare the bFGF- 
PLGA microspheres With the multiple emulsion 
encapsulative method. bFGF-PLGA microspheres can 
preserve the bioactivities of bFGF effectively and promote 
the proliferation of Schwann cells in a long period because 
of the controlled release of bFGF from the microspheres. 
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In this study, polylactic-co-glycolic acid ( PLGA) 
was used as the coating material, and a multi-emulsion 
encapsulating mechanism was used in the preparation 
of controlled release microspheres incorporating bFGF. 
Its morphology, particle size distribution, drug 
loading, enveloping rate and in vitro release property 
were studied. In addition, cytometry , cytoactivity 
detection and mitotic cycle analysis were performed in 
order to achieve a preliminary idea about the bioactivity 
of the bFGF being released from the controlled release 
microspheres through adding the bFGF microspheres 
into the culture medium of the Schwann cells. 
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METHODS 
Reagent and equipment 
Freeze-dried bFGF powder ( EssexBio , China ) , 
Polylactic-co-glycolic acid copolymer ( Chengdu 
Institute of Organic Chemistry, Chinese Academy of 
Sciences, Mv 12 000, 50: 50) , Rabbit polyclonal 
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antibody against bovine bFGF ( Sigma, USA ) , Goat 
antibody against rabbit IgG marked with horseradish 
peroxidase enzyme ( Beijing Zhongshan Biotech Ltd 
Co. , China ) , Polyclonal antibody against S-100 
protein (Beijing Zhongshan Biotech Ltd Co. , China) , 
Dulbecco’ s Modified Eagle ’ s Medium ( DMEM, 
Gibco , USA ) , Type- II Collagenase ( Sigma, USA ) , 
Trypsin ( Sigma, USA ) , Collagen ( Sigma, USA ) , 
Methylthiazolyl tetrazolium ( M l T  Sigma , USA ) . 
IS-80M speeding refrigeration centrifuge ( USA) , 
AMRAY electronic scanning microscopy ( USA ) , 
Malvern mastersizer 2000 laser particle size distribution 
tester ( USA) , Lyophilizer ( Savant Modulyo, USA) , 
Bio-RAD Model 550 photodensitometer ( USA) , Flow 
cytometer (Elite SP, USA) , Class II A/B3 biological 
safety cabinet ( USA) , CO, gas incubator ( Sanyo, 
Japan ) , Refrigeration centrifuge ( Megafuge 1. OR, 
U S A ) .  
Preparation of bFGF-PLGA controlled release 
microspheres 
According to the optimized prescription obtained 
from the preliminary test, PLGA was dissolved by the 
dichloromethane solution. Once completely dissolved, 
the bFGF solution was added and the mixture was 
homogenized by ultrasonic wave into emulsion. 6% 
polyvinyl alcohol ( PVOH) solution was used as the 
aqueous phase dispersed medium, whose inorganic salt 
concentration was 2 % .  2 ml PVOH solution was then 
mixed into the emulsion. After completely stirred, the 
emulsion was added into 8 ml polyvinyl alcohol 
(PVOH) solution of the same concentration, stirred by 
magnetic force under ambient temperature until the 
complete volatilization of the dichloromethane , and the 
colloid solution of bFGF-PLGA controlled release 
microspheres was then obtained. Proper amount of 1% 
lactose as frame materials was added into the 
microsphere solution which was conserved under freeze- 
dried circumstance. 
Morphology and particle size distribution of bFGF- 
PLGA microspheres 
Electronic scanning microscopy was used to 
observe the morphology of bFGF-PLGA microspheres. 
Malvern laser particle size distribution tester was used 
to determine the particle size of the bFGF-PLGA 
microspheres. The size distribution of the bFGF-PLGA 
microspheres was calculated according to the Chinese 
Dispensary2000 : sizedistribution = ( D9O-DlO)/D50. 
Examination of drug loading and enveloping rate of 
the bFGF-PLGA microspheres 
The enzyme linked immunosorbent assay 
(ELISA ) was used to examine the absorbency ( A 
value) of the standard bFGF solution. The A value was 
used for the logarithm linear regression of the standard 
bFGF solution and the equation was established. 
Certain amount of newly prepared bFGF-PLGA 
microspheres was obtained and centrifuged at 40 000 
r/min under 4°C for 2 hours. The ELISA was used to 
determine the A value of the supernatant fluid and the 
floating drug load ( the drug load in the liquid 
medium) was calculated according to the regression 
equation. The drug loading and enveloping rate were 
then obtained according to the formulations. 
I n  vitro drug release of bFGF-PLGA microspheres 
According to the drug loading, bFGF-PLGA 
microspheres which contain 1. 5 pg bFGF were added 
into centrifugal tubes ( n = 3 ) .  Then 2 ml normal 
saline was added into each tube and oscillated with 
constant temperature and speed (37°C and 20 r/min) . 
The concentrations of bFGF in the supernatant fluid 
from the centrifuge tubes were measured at 12,  24, 
36, 48, 60, 72, 84 hours and 5 ,  6,  7 ,  8 ,  9 ,  10, 11 
days respectively. The original volumes were restored 
after sampling. The bFGF-PLGA microspheres 
releasing curve was drawn according to the 
accumulated release rate and time data. 
Cultivation, identification and grouping of 
Schwann cells 
Primary Schwann cells, which were obtained from 
bilateral sciatic nerves of newborn New Zealand 
rabbits, were cultivated using a combination of enzymic 
digestion and repeated attachment method. The 
cultivated Schwann cells were identified by 
immunohistochemistry staining using anti-S-100-protein 
polyclonal antibody and then subcultured for the 
subsequent use. Experiment grouping : Group A 
contained 10% calf serum and DMEM with 50 ng/ml 
bFGF; Group B contained 10% calf serum and DMEM 
with bFGF-PLGA microspheres which contain 50 
ng/ml bFGF. 
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Effect of bFGF-PLGA microspheres on the 
cytometry , cytoactivity and mitotic cycle of 
Schwann cells 
The 3rd subcultivated generation of Schwann cells 
with the concentration of 1 x 104/ml were inoculated 
into a 24-well plate, 1 ml in each pore. When the cells 
reached an identical level of growth, different culture 
fluids were exchanged according to different groups. 
Cell samples of 2 wells in each group were collected at 
the l s t ,  2nd, 3rd, 4th, 6th, 8th days and the cell 
numbers were calculated by haemocytometer , which 
were repeated three times. 
The 3rd subcultivated generation of Schwann cells 
with the concentration of 1 x 104/ml were inoculated 
into a 96-well plate, 200 pl in each pore. When the 
cells reached an identical level of growth, different 
culture fluids were exchanged according to different 
groups. Cell samples of 4 wells in each group were 
collected at the Ist ,  2nd, 3rd, 4th, 6th, 8th days. 
According to the regulation of MTl’ method, 
methylthiazolyl tetrazolium and dimethyl sulfoxide were 
added 4 hours before the collection, and ELISA reader 
was used to examine the absorbance ( A  value) of each 
well at 490 mm wave length. This procedure was 
repeated three times. 
RESULTS 
Morphological observation of bFGF-PLGA 
microspheres 
The bFGF-PLGA microspheres had smooth round 
surfaces, uniform partical size and no adhesion were 
observed. The mean partical size was ( 1.552 f 
0.015 ) p m  and the mean size distribution was 1.310 f 
0.010, which showed that the particle distribution was 
narrow and their sizes were uniform ( Fig. 1 ) . 
Drug loading and enveloping rate of bFGF-PLGA 
microspheres 
The regression equation obtained from the 
standard bFGF solution was C = 1127.81 xA-20. 72,  r 
= O .  9697. The drug loading and enveloping rate of 
bFGF-PLGA microspheres were ( 27.18 x lo5 ) f 
(0.51 x lo5 ) % and (66.43 +, 1.24)  % respectively 
(Table 1 ) . 
Table 1. Drug-loading and enveloping rate of 
bFGF-PLGA rnicrosDheres 
Batch No. Drug loading ( 10” ) Enveloping rate ( % ) 
1 26.42 65.67 
2 27.04 66.32 
3 28.08 67.30 
The 3rd subcultivated generation of Schwann cells 
with the concentration of 4 x 104/ml were inoculated 
into a 6-well plate, 1 ml in each pore. When the cells 
reached an identical level of growth, different culture 
fluids were exchanged according to different groups. 
Cell samples of 2 wells in each group were collected on 
the 2nd, 4th,  8th days. Cell mitotic cycle was 
examined by flow cytometer, and the percentages of 
G2/M + S were calculated. This procedure was 
repeated three times. 
Statistical analysis 
standard deviation ( X * s ) . Statistical analysis was 
done by using SPSS software. P < 0.05 is considered 
to be statistically significant. Student’ s t-test was used 
for the comparison of two groups and ANOVA was used 
for the comparison of multiple groups. 
The results were demonstrated in terms of mean 
In vitro drug release of bFGF-PLGA microspheres 
Within the 11 days period, bFGF were released 
from the microspheres constantly and cumulatively. 
The concentration of bFGF was in a range of 71.47- 
89.81 ng/ml while the overall releasing rate reached 
72.47% at the 11th day. 
Cultivation and identification of Schwann cells 
The typical Schwann cells are fusiform with two 
slender prominencies at the two poles. The nucleus is 
elliptical, seating at one side of the cell body. 
Immunohistochemistry staining of polyclonal antibody of 
S-100 protein showed a diffuse positive reaction in the 
cytoplasm ( Figs. 2 ,  3 ) . 
Effect of bFGF-PLGA microspheres on the 
cytometry of Schwann cells 
The number of cultured Schwann cells at different 
time points showed that: 1 , 2 days after plate culture, 
the number of Schwann cells of the bFGF group was 
statistically more than that of bFGF-PLGA group 
Chinese Journal of Traumatology 2008; 11 ( 1  ) : 22-27 - 25 - 
( P  < O .  0 5 )  ; 3 ,  4 days after plate culture, the number 
of bFGF group and bFGF-PLGA group showed no 
difference ( P > 0.05 ) ; 6 ,  8 days after plate culture, 
the cell number of bFGF-PLGA group was statistically 
more than that of bFGF group ( P  <O. 05, Table 2 ) .  
Effect of bFGF-PLGA microspheres on the vitality 
of Schwann cells 
The A values of cultured Schwann cells at different 
time points showed : 1 , 2 days after plate culture, the 
A values of bFGF group were statistically higher than 
those of bFGF-PLGA group ( P < 0. 05 ) ; 3 ,  4 days 
after plate culture, the A values of bFGF group and 
bFGF-PLGA group showed no significant difference ( P 
> 0.05 ) ; 6 ,  8 days after plate culture, the A values of 
bFGF-PLGA group were statistically higher than those 
of bFGF group( P < 0.05 , Table 3 ) . 
Effect of bFGF-PLGA microspheres on the mitotic 
cycle of Schwann cells 
The examinations of mitotic cycles of Schwann 
cells at different time points showed that: 2 days after 
plate culture, the G2/M + S percentage of bFGF group 
was statistically higher than that of bFGF-PLGA group 
( P < 0.05 ) i 4, 8 days after plate culture, the G2/M 
+ S percentage of bFGF-PLGA group was statistically 
higher than that of bFGF group ,( P < 0.05 , Table 4). 
Table 2. Effect of bFGF-PLGA microspheres on the cytometry of Schwann cells ( x 104/ml, 2 ~t s )  
Time points ( d)  
1 2 3 4 6 8 
Groups 
bFGF 3.75 i 0.43 * 9.00 r I .  52 * 12.25 i 2.18 16.42 f 2.75 18. I7 i 2. 13 20.08 f 2.47 
bFGF-PLGA 2.42 +O. 38 5.67 * 1.28 13.42k1.89 16.83*2.24 23 .58i2 .67"  25 .33i2 .24 '  
t values 4 2.902 0 . 7  0.203 3.610 3.261 
P values 0.016 0.044 0.523 0.849 0.015 0.022 
* Statistical difference between the bFGF group and bFGF-PLGA group, P <O. 05 
Table 3. Effect of bFGF-PLGA microspheres on the viability of Schwann cells ( A  value, X f s )  
~~~~ ~~~ ~ 
Time points (d )  
7 3 A 6 8 
Groups 
1 
bFGF 0. 167 k0. 023 * 0.209 *O. 036 * 0.244 i 0.026 0.272 to. 029 0.293 e0.030 0.321 * O .  026 
bFGF-PLGA 0.121 +0.011 0.136*0.021 0.240k0.040 0.275*0.035 0.354+0.031 * 0 .387~0 .031 '  
1 values 3.179 3.039 0.158 0.115 2.935 2.865 
P values 0.034 0.038 0.882 0.914 0.032 0.046 
* Statistical difference between the bFGF group and bFGF-PLGA group, P <O. 05. 
Fig. 1. SEM of the bFGF-PLGA microspheres: The morphology and the particle size of the microspheres are even and good ( x 4OOO) 
Fig. 2. Irnmunohistochemistry staining of the Schwann cells showing the diffuse positive reaction in the cytoplasm ( Sl00 IHC x 100). 
Fig. 3. Immunohistochemistry staining of the Schwann cells showing the negative reaction in the cytoplasm if the antibody is replaced 
by PBS ( 900 IHC x 100). 
* 26 * Chinese Journal of Traumatology 2008; ii ( i ) : 22-27 
Table 4. Effect of bFGF-PLGA microspheres on the mitotic 
cycle of Schwann cells ( G2/M + S percentage, X f s )  
Time points ( d )  
8 Groups 2 4 
bFGF 19.70*3.80* 13.17k3.53 9 .83 i2 .41  
bFGF-PLGA 1 1.47 * 2.51 19.03 * 2.45 * 18.80 i 2.07 * 
t values 3.130 2.821 4.893 
P values 0.035 0.037 0.008 
* Statistical difference between the bFGF p u p  and bFGF-PLGA 
group, P < 0.05. 
DISCUSSION 
By using natural or synthetic high molecule 
materials, drugs could be microcapsulated into 
microspheres with a diameter of 1-5 OOO pm 
( commonly 2-250 pm ) which own prolonged 
therapeutic effects, improved stability, reduced 
peculiar smell and side effects. The ideal microspheres 
prepared with biodegradable high molecular materials 
can achieve a stable characteristic and a good 
biocompatibility. After applying a single dose, the 
drug could keep releasing for a longer time. 
Furthermore, once complete release is completed, the 
coat material could self-eliminate in uivo through 
biodegradation. This can provide great facility for the 
use of steroidal drugs that have low dissolubility and 
slow velocity of infiltration, and polypeptide hormone 
drugs that would easily loose their bioactivities. 3 9  As a 
polypeptide growth factor in possession of extensive 
bioactivities, bFGF is sensitive to heat or acid and has 
a short half-life time just like most growth factors. So 
this study utilizes the degradable material for the 
preparation of bFGF microspheres in order to achieve 
the controlled release of the drug and the maintenance 
of the stable local concentration in a certain period. 
The carrier used in the preparation of bFGF 
controlled release microspheres could be divided into 
natural, semi-synthetic and synthetic materials, and 
the PLGA used in this study belongs to synthetic high 
molecule material, which hold the advantages of non- 
toxic, good biocompatibility , controllable degrading 
time and that the material and degradable production is 
hamless to the drug. Pean et a15 injected the PLGA 
microspheres into the cerebra of rats, and the result 
showed a normal morphology of the surrounding nerve 
cells and no toxic reaction was revealed. Lohmann et 
a16 planted the chondrocytes onto the PLGA frame 
which had been preprocessed with PDGF, and found 
that not only the chondrocytes could adhere onto the 
frame, but also there were newly formed cartilages at 
the sites of plant. The PLGA material has been used in 
the preparation of the microspheres of several factors 
such as TGF-P, IGF, GH, and so on, and the 
controlled release effect and the conservation of drug’ s 
bioactivities are satisfactory. This study uses PLGA as 
coating material in the preparation of bFGF 
microspheres, and the results showed that the surfaces 
of the bFGF-PLGA microspheres were round and 
smooth, the spheres were symmetrical and no adhesion 
was found. The mean partical size was 1.552 + O .  015 
p m  and the mean size distribution was 1.310 kO.010, 
which showed that the particle distribution was narrow 
and their sizes were uniform. 
Drug loading and enveloping rates are two 
important indices used in the quality assessment of 
microspheric drug loading systems. The technique of 
preparation is an important one in the factors affecting 
the drug loading and enveloping rates. The main 
advantage of the multi-emulsion encapsulating 
mechanism is that when the dissolvent volatilizes, the 
polymers are splinted between the two aqueous phases 
and prevent the infiltration of drugs that are kept in the 
inner phase. So the microspheres prepared in this way 
have higher drug loading and enveloping rates 
compared with other methods using the same material. 
Blanco-Prieto et al’ used this method in preparation of 
somatostatin microspheres and the enveloping rate 
achieved 95%. In this study, the bFGF-PLGA 
microspheres prepared in the way of multi-emulsion 
encapsulating mechanism achieved a drug loading and 
enveloping rates of (27. 18 x l o ” )  f (0.51 x l o ” ) %  
and ( 66. 43 +. 1. 24 ) %  respectively, which have 
approved its efficiency and feasibility. 
Another important index used in the assessment of 
drug loading system is the in uitro drug releasing rate. 
In this study, bFGF was released from microspheres 
constantly and stably within the 11 days period. The 
concentration of bFGF lies in a range of 71.47-89.81 
ng/ml while the overall releasing rate was 72.47% at 
the 11 st day, suggesting that in a short period after the 
preparation of bFGF-PLGA microspheres , bFGF could 
be released slowly and steadily. 
The conservation of the bioactivities is the fourth 
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important index in a quality assessment of the 
microsperes after the preparation. Edelman et a19 
prepared the bFGF-EVAc controlled release 
microspheres using the phase segregation method and 
99% of the bioactivities of bFGF lost after the 
preparation. The efficiency of the microspheres is 
rather poor. The use of PLGA, which is degradable as 
the carrier for microspheres, not only could keep the 
release of the drug in a controlled way, but also protect 
the growth factor ’ s activities in the facilities of the 
hydrophobic properties. In this study, the 
characteristic that bFGF could promote the proliferation 
of the Schwann cells was utilized. l o *  The conservation 
of the bioactivities of bFGF in the microspheres was 
assessed through the cytometry , cytoactivity detection 
and mitotic cycle analysis of Schwann cells. The result 
showed that at the beginning of the cultivation, the 
proliferation-promoting effect of the bFGF group 
preceded that of the bFGF-PLGA group; however, late 
in the cultivation, the proliferation-promoting effect of 
the bFGF-PLGA group preceded that of the bFGF 
group, which suggests that : 1 ) because of the equally 
total amount of bFGF, there is more amount of free 
bFGF in the bFGF group than the bFGF-PLGA group 
at the beginning of the cultivation, so there is more 
proliferation-promoting effect in the bFGF group; 2 ) 
late in the cultivation, most free bFGF in the bFGF 
group has lost their bioactivities while the bFGF that 
possesses their bioactivities keeps releasing in the 
bFGF-PLGA group and achieves a strong effect of 
promoting proliferation ; 3 ) PLGA not only meets the 
requirement of controlled release, but also conserves 
the bioactivities of the released bFGF. 
In conclusion, PLGA is an ideal carrier material 
in preparation of the bFGF microspheres, and bFGF- 
PLGA microspheres have a simple preparation 
technique and an excellent controlled releasing 
property. It could keep releasing bFGF possessing good 
bioactivities and thereupon stimulate the mitosis and 
proliferation of Schwann cells in a relatively prolonged 
period. 
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